740 related articles for article (PubMed ID: 31134088)
1. Interleukin-35 Dampens CD8
Yang L; Shao X; Jia S; Zhang Q; Jin Z
Front Immunol; 2019; 10():1032. PubMed ID: 31134088
[TBL] [Abstract][Full Text] [Related]
2. Interleukin-35 Suppresses CD8
Yang L; Zhang Q; Song J; Wang W; Jin Z
Dig Dis Sci; 2020 Dec; 65(12):3614-3623. PubMed ID: 31974915
[TBL] [Abstract][Full Text] [Related]
3. Interleukin-7 enhances anti-tumor activity of CD8
Teng D; Ding L; Cai B; Luo Q; Wang H
Cytokine; 2019 Jun; 118():115-123. PubMed ID: 29655570
[TBL] [Abstract][Full Text] [Related]
4. Interleukin-35 suppresses the activity of natural killer-like B cells in patients with hepatocellular carcinoma.
Liu S; Yang L; Jia S; Zhao R; Jin Z
Int Immunopharmacol; 2021 Nov; 100():108161. PubMed ID: 34555643
[TBL] [Abstract][Full Text] [Related]
5. Interleukin-35 Suppresses Interleukin-9-Secreting CD4
Zhang Q; Yang L; Liu S; Zhang M; Jin Z
Front Immunol; 2021; 12():645835. PubMed ID: 34177894
[TBL] [Abstract][Full Text] [Related]
6. Interleukin-35 Suppresses Antiviral Immune Response in Chronic Hepatitis B Virus Infection.
Shao X; Ma J; Jia S; Yang L; Wang W; Jin Z
Front Cell Infect Microbiol; 2017; 7():472. PubMed ID: 29181338
[TBL] [Abstract][Full Text] [Related]
7. Interleukin-37 suppresses the cytotoxicity of hepatitis B virus peptides-induced CD8+ T cells in patients with acute hepatitis B.
Liu Q; Zhou Q; Wang M; Pang B
Biomol Biomed; 2023 May; 23(3):527-534. PubMed ID: 36326182
[TBL] [Abstract][Full Text] [Related]
8. Interleukin-35 has a Protective Role in Infectious Mononucleosis-Induced Liver Inflammation Probably by Inhibiting CD8
Gao Y; Li L; Hu X; Zhang W; Li Y
Arch Immunol Ther Exp (Warsz); 2022 Oct; 70(1):25. PubMed ID: 36219249
[TBL] [Abstract][Full Text] [Related]
9. PD1
Ma J; Zheng B; Goswami S; Meng L; Zhang D; Cao C; Li T; Zhu F; Ma L; Zhang Z; Zhang S; Duan M; Chen Q; Gao Q; Zhang X
J Immunother Cancer; 2019 Nov; 7(1):331. PubMed ID: 31783783
[TBL] [Abstract][Full Text] [Related]
10. Notch signaling pathway suppresses CD8
Li S; Wang Z; Li XJ
Int Immunopharmacol; 2018 Oct; 63():129-136. PubMed ID: 30086535
[TBL] [Abstract][Full Text] [Related]
11. Interleukin-7 augments CD8
Hou H; Kang Y; Zeng Y; Li Y; Shang J
Cytokine; 2018 Feb; 102():26-33. PubMed ID: 29275010
[TBL] [Abstract][Full Text] [Related]
12. Interleukin-35 has a tumor-promoting role in hepatocellular carcinoma.
Liu X; Ren H; Guo H; Wang W; Zhao N
Clin Exp Immunol; 2021 Feb; 203(2):219-229. PubMed ID: 33030251
[TBL] [Abstract][Full Text] [Related]
13. Tumor-activated monocytes promote expansion of IL-17-producing CD8+ T cells in hepatocellular carcinoma patients.
Kuang DM; Peng C; Zhao Q; Wu Y; Zhu LY; Wang J; Yin XY; Li L; Zheng L
J Immunol; 2010 Aug; 185(3):1544-9. PubMed ID: 20581151
[TBL] [Abstract][Full Text] [Related]
14. Interleukin-17-educated monocytes suppress cytotoxic T-cell function through B7-H1 in hepatocellular carcinoma patients.
Zhao Q; Xiao X; Wu Y; Wei Y; Zhu LY; Zhou J; Kuang DM
Eur J Immunol; 2011 Aug; 41(8):2314-22. PubMed ID: 21674477
[TBL] [Abstract][Full Text] [Related]
15. Aberrant expression of p-STAT3 in peripheral blood CD4+ and CD8+ T cells related to hepatocellular carcinoma development.
Wang X; Xin W; Zhang H; Zhang F; Gao M; Yuan L; Xu X; Hu X; Zhao M
Mol Med Rep; 2014 Nov; 10(5):2649-56. PubMed ID: 25175640
[TBL] [Abstract][Full Text] [Related]
16. γδ T cells in hepatocellular carcinoma patients present cytotoxic activity but are reduced in potency due to IL-2 and IL-21 pathways.
Jiang H; Yang Z; Song Z; Green M; Song H; Shao Q
Int Immunopharmacol; 2019 May; 70():167-173. PubMed ID: 30802679
[TBL] [Abstract][Full Text] [Related]
17. Interleukin-35 suppresses antitumor activity of circulating CD8
Liu MX; Liu QY; Liu Y; Cheng ZM; Liu L; Zhang L; Sun DH
Connect Tissue Res; 2019 Jul; 60(4):367-375. PubMed ID: 30616389
[No Abstract] [Full Text] [Related]
18. Interleukin-7 promotes CD8
Tian X; Su Z; Guo S; Wang C; Zhang X; Du J
Int Immunopharmacol; 2019 Oct; 75():105773. PubMed ID: 31349155
[TBL] [Abstract][Full Text] [Related]
19. alpha-fetoprotein and interleukin-18 gene-modified dendritic cells effectively stimulate specific type-1 CD4- and CD8-mediated T-Cell response from hepatocellular carcinoma patients in Vitro.
Cao DY; Yang JY; Dou KF; Ma LY; Teng ZH
Hum Immunol; 2007 May; 68(5):334-41. PubMed ID: 17462500
[TBL] [Abstract][Full Text] [Related]
20. Liver-infiltrating CD8(+) lymphocytes as prognostic factor for tumour recurrence in hepatitis C virus-related hepatocellular carcinoma.
Ramzan M; Sturm N; Decaens T; Bioulac-Sage P; Bancel B; Merle P; Tran Van Nhieu J; Slama R; Letoublon C; Zarski JP; Jouvin-Marche E; Marche PN; Leroy V
Liver Int; 2016 Mar; 36(3):434-44. PubMed ID: 26215124
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
